LVEM25 & Pharmaceuticals
Roche Diagnostics GmbH have entrusted the LVEM25 as one of their new research tools to help bring new medical care products to market. Roche is currently the world's largest biotech company and the current leading provider of cancer treatments worldwide.
With its powerful 1.0 nm resolution and high-throughput capabilities, the LVEM25 is proving itself as a very handy tool in the ever growing nano-field of drug delivery and pharmaceuticals.
For more on Roche Diagnostics, click here.
For more details on the LVEM25, click here.